Investing Profile

Alex Morgan

VCInvestor
Partner at Khosla Ventures
Photo of Alex Morgan, Partner at Khosla Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $50.0M
$25.0M
23
$1.1B
CompanyStageDateRound SizeTotal Raised
Synchron
Series DNov 2025$200M
$320M
Co-investors: Ari Nowacek (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Thomas Reardon (PSG)
Faeth Therapeutics
Series AOct 2025$25M
Series AJun 2022$47M
SeedJan 2022$20M
$92M
CHARM Therapeutics
Series BSep 2025$80M
Series AJun 2022$50M
$130M
Co-investors: Chris Bischoff (General Catalyst), Matthew McAviney (New Enterprise Associates (NEA)), Rishi Gupta (OrbiMed), Muzammil Mansuri (F-Prime Capital Partners), Nihal Sinha (F-Prime Capital Partners)
Circulate
SeedJun 2025$12M
$14M
Co-investors: Madeleine Magnerius (EQT Partners), Sanna Westman (Creandum), Borja Moreno de los Rios (Silence), Susanna Campbell
Inflammatix
Series ESep 2024$57M
$57M
Karius
Series CMay 2024$100M
$160M
Co-investors: Kyle Kurpinski (Tencent Holdings), Isabelle de Cremoux (Seventure Partners)
Rubedo Life Sciences
Series AApr 2024$40M
$52M
Co-investors: David Shapiro (Alumni Ventures ), Laura Deming (The Longevity Fund), Chiara Castelli (Moonstone Venture Capital), Alice Newcombe-Ellis (Ahren Innovation Capital), Emil Waskoenig (Moonstone Venture Capital)
Loyal
Series BMar 2024$45M
Series ASep 2021$27M
$83M
Co-investors: Claire Hughes Johnson, Andy Coravos